Key Highlights
•
A landmark 1985 study discovered that retroviruses can trick the cellular machinery that reads genetic code, causing it to “slip” and produce different proteins from the same sequence. This discovery, known as programmed ribosomal frameshifting, later inspired scientists to search for and find this same phenomenon in vertebrates, revealing a new layer of genetic regulation.
Source →
•
Researchers have developed a new dynamic benchmark for testing how well computer programs can predict how drugs bind to proteins, moving beyond static snapshots. This tool, called DynaBench, provides more realistic data that accounts for the natural flexibility of molecules, which is crucial for designing better and more effective medicines.
Source →
•
Scientists have uncovered a new quality control system in fungal cells that helps them recover from stress by cleaning up and segregating damaged parts of a key cellular structure called the nucleolus. This chaperone-mediated process ensures that when the cell divides, the new cells inherit a “rejuvenated” nucleolus, which is vital for maintaining cellular health in complex, multi-nucleated organisms.
Source →
•
The well-known tumor suppressor protein PP2A can switch the way the cancer-driving protein c-Myc is degraded in cells, depending on the levels of a specific PP2A complex. This resolves a long-standing paradox in cancer biology and reveals a new mechanism that cancer cells might exploit to keep c-Myc levels high and drive uncontrolled growth.
Source →
•
A new review highlights the mysterious Leishmania martiniquensis parasite and its relatives, which are emerging pathogens that cause leishmaniasis, a serious infectious disease. These parasites are reshaping our understanding of the disease because they belong to a distinct evolutionary group and exhibit unique biological characteristics compared to traditional Leishmania species.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
